Practical management of patients treated with α interferon

Acta Gastro-Enterologica Belgica

Volumn 60, Issue 3, 1997, Pages 211-213

  Brenard, R ^a  

^a Hopital St Joseph   (Belgium)

Author keywords

Chronic viral hepatitis; Interferon; Side effects

Indexed keywords

ALPHA INTERFERON;

CHRONIC HEPATITIS; CONFERENCE PAPER; DEPRESSION; HUMAN; LIVER CIRRHOSIS; PSORIASIS; SUICIDE; THYROID DISEASE;

ANTIVIRAL AGENTS; BELGIUM; CHRONIC DISEASE; DRUG ERUPTIONS; HEPATITIS, VIRAL, HUMAN; HUMANS; INTERFERON-ALPHA; LIVER DISEASES; MENTAL DISORDERS; PRACTICE GUIDELINES; THYROID DISEASES;

EID: 0030703201     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. RENAULT P F., HOOFNAGLE J.H. Side effects of alpha Interferon. Sem. Liv. Dis., 1989, 9. 273-277
2. VIAL T , BAILLY F., DESCOTES J., TREPO C Effets secondaires de l'interféron alpha. Gastroenterol Clin. Biol. 1996, 20, 462-489.
3. MARCELLIN P., POUTEAU M., BENHAMOU J.P. Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction. J. Hepatol., 1995, 22, 364-369
4. LISKER-MELMAN M , DI BISCEGLIE A., USALA S., WEINTRAUB B., MURRAY L., HOOFNAGLE J. Development of thyroid disease during therapy of chronic viral hepatitis with interferon alpha. Gastroenterology, 1992. 102, 2155-2160.
5. VIAL T., DESCOTES J. Clinical toxicity of the interferons. Drug safety, 1994, 10, 115-150
6. QUESADA J., TALPAZ M., RIOS A., KURZROCK R , GUTTERMAN J Clinical toxicity of interferons in cancer patients a review. J Clin Oncol , 1986, 4, 234-243
7. MARCELLIN P., COLIN J.F., BOYER N , BERNUAU J., DEGOTT C , HIRSCHAUER, et al. Fatal exacerbation of chronic hepatitis B induced by recombinant alpha-interferon. Lancet, 1991, 338, 828.
8. JANSSEN H , BROUWER J., NEVENS F., SANCHEZ-TAPIAS J., CRAXI A., HADZIYANNIS S. Fatal hepatic decompensation associated with interferon alpha. Lancet, 1993, 306, 107-108.
9. PAPO T., MARCELLIN P., BERNUAU J., DURAND F., POYNARD T. et al Autoimmune chronic hepatitis exacebed by alpha-interferon. Ann. Int. Med., 1992, 116, 51-53
10. TRAN A., BEUSNEL C., MONTOYA M , LUSSIEZ V., HÉBUTERNE X. et al. Hépatite auto-immune de type 1 révélée par un traitement par interféron Gastroenterol. Clin. Biol. 1992, 16, 722-723.
11. PRASAD S., WATERS B , HILL P., POETERA P., RIELY C. Psychiatric sice effects of interferon alpha 2b in patients treated for hepatitis C. Clin Res., 1992, 40, 840A.
12. JANSSEN H , BROUWER J., VAN DER MAST R., SCHALM S. Suicide associated with alfa-interferon therapy for chronic viral hepatitis J. Hepatol., 1994, 21, 241-243.
13. RENAULT P., HOOFNAGLE J., PARK Y , MULLEN K., PETERS M., JONES B. et al. Psychiatric complications of long-term interferon alpha therapy. Arch Intern Med , 1987, 147, 1577-1578.
14. MC DONALD E , MANN A., THOMAS H. Interferons as mediators of psychiatric morbidity Lancet, 1987, 2, 1175-1177.
15. STRUMIA R , VENTURINI D , BOCCIA S. UVA and interferon therapy in a patient with lichen planus and chronic hepatitis C. Int. J. Dermatol., 1993, 22, 386.